Connection

Gunnar Gislason to Platelet Aggregation Inhibitors

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Platelet Aggregation Inhibitors.
Gunnar Gislason
Connection Strength
0.265
Platelet Aggregation Inhibitors
  1. Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011. PLoS One. 2018; 13(3):e0194295.
    View in: PubMed
    Score: 0.083
  2. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart. 2018 06; 104(11):912-920.
    View in: PubMed
    Score: 0.081
  3. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life. JACC Heart Fail. 2019 07; 7(7):561-570.
    View in: PubMed
    Score: 0.023
  4. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease. J Am Coll Cardiol. 2018 10 09; 72(15):1790-1800.
    View in: PubMed
    Score: 0.022
  5. Reply: Aspirin and Prognosis in Heart Failure: A Question of Power. JACC Heart Fail. 2018 06; 6(6):540.
    View in: PubMed
    Score: 0.021
  6. Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study. JACC Heart Fail. 2018 02; 6(2):156-167.
    View in: PubMed
    Score: 0.021
  7. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation. 2012 Sep 11; 126(11):1345-54.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.